UnitedHealth Group Incorporated (NYSE:UNH) Holdings Cut by Codex Capital Asset Management L.L.C.

Codex Capital Asset Management L.L.C. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 63.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,000 shares of the healthcare conglomerate’s stock after selling 1,700 shares during the quarter. Codex Capital Asset Management L.L.C.’s holdings in UnitedHealth Group were worth $514,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter worth $30,000. Promus Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter worth about $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $40,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH opened at $503.61 on Wednesday. The company’s 50 day simple moving average is $510.90 and its 200-day simple moving average is $548.54. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $460.66 billion, a P/E ratio of 32.49, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.67%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on UNH shares. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.